Shares of Clinical Data got a modest boost on the news that its late-stage study of the antidepressant Vilazodone produced positive results. A companion pharmacogenetic test may make it easier to identify the patients most likely to benefit. Release [1]
Links:
[1] http://www.fiercebiotech.com/press-releases/press-release-clinical-data-announces-positive-results-phase-iii-pivotal-trial-vilazo